Report Overview
Molecular-targeted therapy is a novel strategy born from our increasing understanding of the underlying pathways and key molecules involved in tumor growth and progression. Theoretically, the specificity of molecular targeted therapy should improve the therapeutic window by affecting the tumor cells and sparing normal cell.
The global Molecular Targeted Therapy market size was estimated at USD 139 million in 2023 and is projected to reach USD 333.16 million by 2032, exhibiting a CAGR of 10.20% during the forecast period.
North America Molecular Targeted Therapy market size was estimated at USD 42.83 million in 2023, at a CAGR of 8.74% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Molecular Targeted Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Targeted Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Targeted Therapy market in any manner.
Global Molecular Targeted Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Phoenix Molecular Designs
Prelude Therapeutics
Tempus
Bracco
iOmx Therapeutics
OncoDNA
Sapience Therapeutics
Caris Life Sciences
Hera Biolabs
CV6 Therapeutics
Carrick Therapeutics
Foundation Medicine
Cybrexa Therapeutics
Market Segmentation (by Type)
Monoclonal Antibodies
Small Molecule Inhibitors
Market Segmentation (by Application)
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Targeted Therapy Market
Overview of the regional outlook of the Molecular Targeted Therapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Molecular Targeted Therapy
1.2 Key Market Segments
1.2.1 Molecular Targeted Therapy Segment by Type
1.2.2 Molecular Targeted Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Molecular Targeted Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Molecular Targeted Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Molecular Targeted Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Molecular Targeted Therapy Market Competitive Landscape
3.1 Global Molecular Targeted Therapy Sales by Manufacturers (2019-2025)
3.2 Global Molecular Targeted Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Molecular Targeted Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Molecular Targeted Therapy Sales Sites, Area Served, Product Type
3.6 Molecular Targeted Therapy Market Competitive Situation and Trends
3.6.1 Molecular Targeted Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Molecular Targeted Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Molecular Targeted Therapy Industry Chain Analysis
4.1 Molecular Targeted Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Molecular Targeted Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Molecular Targeted Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Targeted Therapy Sales Market Share by Type (2019-2025)
6.3 Global Molecular Targeted Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Molecular Targeted Therapy Price by Type (2019-2025)
7 Molecular Targeted Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Targeted Therapy Market Sales by Application (2019-2025)
7.3 Global Molecular Targeted Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Molecular Targeted Therapy Sales Growth Rate by Application (2019-2025)
8 Molecular Targeted Therapy Market Consumption by Region
8.1 Global Molecular Targeted Therapy Sales by Region
8.1.1 Global Molecular Targeted Therapy Sales by Region
8.1.2 Global Molecular Targeted Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Molecular Targeted Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Molecular Targeted Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Molecular Targeted Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Molecular Targeted Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Molecular Targeted Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Molecular Targeted Therapy Market Production by Region
9.1 Global Production of Molecular Targeted Therapy by Region (2019-2025)
9.2 Global Molecular Targeted Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Molecular Targeted Therapy Production
9.4.1 North America Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.4.2 North America Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Molecular Targeted Therapy Production
9.5.1 Europe Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Molecular Targeted Therapy Production (2019-2025)
9.6.1 Japan Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Molecular Targeted Therapy Production (2019-2025)
9.7.1 China Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.7.2 China Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Phoenix Molecular Designs
10.1.1 Phoenix Molecular Designs Molecular Targeted Therapy Basic Information
10.1.2 Phoenix Molecular Designs Molecular Targeted Therapy Product Overview
10.1.3 Phoenix Molecular Designs Molecular Targeted Therapy Product Market Performance
10.1.4 Phoenix Molecular Designs Business Overview
10.1.5 Phoenix Molecular Designs Molecular Targeted Therapy SWOT Analysis
10.1.6 Phoenix Molecular Designs Recent Developments
10.2 Prelude Therapeutics
10.2.1 Prelude Therapeutics Molecular Targeted Therapy Basic Information
10.2.2 Prelude Therapeutics Molecular Targeted Therapy Product Overview
10.2.3 Prelude Therapeutics Molecular Targeted Therapy Product Market Performance
10.2.4 Prelude Therapeutics Business Overview
10.2.5 Prelude Therapeutics Molecular Targeted Therapy SWOT Analysis
10.2.6 Prelude Therapeutics Recent Developments
10.3 Tempus
10.3.1 Tempus Molecular Targeted Therapy Basic Information
10.3.2 Tempus Molecular Targeted Therapy Product Overview
10.3.3 Tempus Molecular Targeted Therapy Product Market Performance
10.3.4 Tempus Molecular Targeted Therapy SWOT Analysis
10.3.5 Tempus Business Overview
10.3.6 Tempus Recent Developments
10.4 Bracco
10.4.1 Bracco Molecular Targeted Therapy Basic Information
10.4.2 Bracco Molecular Targeted Therapy Product Overview
10.4.3 Bracco Molecular Targeted Therapy Product Market Performance
10.4.4 Bracco Business Overview
10.4.5 Bracco Recent Developments
10.5 iOmx Therapeutics
10.5.1 iOmx Therapeutics Molecular Targeted Therapy Basic Information
10.5.2 iOmx Therapeutics Molecular Targeted Therapy Product Overview
10.5.3 iOmx Therapeutics Molecular Targeted Therapy Product Market Performance
10.5.4 iOmx Therapeutics Business Overview
10.5.5 iOmx Therapeutics Recent Developments
10.6 OncoDNA
10.6.1 OncoDNA Molecular Targeted Therapy Basic Information
10.6.2 OncoDNA Molecular Targeted Therapy Product Overview
10.6.3 OncoDNA Molecular Targeted Therapy Product Market Performance
10.6.4 OncoDNA Business Overview
10.6.5 OncoDNA Recent Developments
10.7 Sapience Therapeutics
10.7.1 Sapience Therapeutics Molecular Targeted Therapy Basic Information
10.7.2 Sapience Therapeutics Molecular Targeted Therapy Product Overview
10.7.3 Sapience Therapeutics Molecular Targeted Therapy Product Market Performance
10.7.4 Sapience Therapeutics Business Overview
10.7.5 Sapience Therapeutics Recent Developments
10.8 Caris Life Sciences
10.8.1 Caris Life Sciences Molecular Targeted Therapy Basic Information
10.8.2 Caris Life Sciences Molecular Targeted Therapy Product Overview
10.8.3 Caris Life Sciences Molecular Targeted Therapy Product Market Performance
10.8.4 Caris Life Sciences Business Overview
10.8.5 Caris Life Sciences Recent Developments
10.9 Hera Biolabs
10.9.1 Hera Biolabs Molecular Targeted Therapy Basic Information
10.9.2 Hera Biolabs Molecular Targeted Therapy Product Overview
10.9.3 Hera Biolabs Molecular Targeted Therapy Product Market Performance
10.9.4 Hera Biolabs Business Overview
10.9.5 Hera Biolabs Recent Developments
10.10 CV6 Therapeutics
10.10.1 CV6 Therapeutics Molecular Targeted Therapy Basic Information
10.10.2 CV6 Therapeutics Molecular Targeted Therapy Product Overview
10.10.3 CV6 Therapeutics Molecular Targeted Therapy Product Market Performance
10.10.4 CV6 Therapeutics Business Overview
10.10.5 CV6 Therapeutics Recent Developments
10.11 Carrick Therapeutics
10.11.1 Carrick Therapeutics Molecular Targeted Therapy Basic Information
10.11.2 Carrick Therapeutics Molecular Targeted Therapy Product Overview
10.11.3 Carrick Therapeutics Molecular Targeted Therapy Product Market Performance
10.11.4 Carrick Therapeutics Business Overview
10.11.5 Carrick Therapeutics Recent Developments
10.12 Foundation Medicine
10.12.1 Foundation Medicine Molecular Targeted Therapy Basic Information
10.12.2 Foundation Medicine Molecular Targeted Therapy Product Overview
10.12.3 Foundation Medicine Molecular Targeted Therapy Product Market Performance
10.12.4 Foundation Medicine Business Overview
10.12.5 Foundation Medicine Recent Developments
10.13 Cybrexa Therapeutics
10.13.1 Cybrexa Therapeutics Molecular Targeted Therapy Basic Information
10.13.2 Cybrexa Therapeutics Molecular Targeted Therapy Product Overview
10.13.3 Cybrexa Therapeutics Molecular Targeted Therapy Product Market Performance
10.13.4 Cybrexa Therapeutics Business Overview
10.13.5 Cybrexa Therapeutics Recent Developments
11 Molecular Targeted Therapy Market Forecast by Region
11.1 Global Molecular Targeted Therapy Market Size Forecast
11.2 Global Molecular Targeted Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Molecular Targeted Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Molecular Targeted Therapy Market Size Forecast by Region
11.2.4 South America Molecular Targeted Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Molecular Targeted Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Molecular Targeted Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Molecular Targeted Therapy by Type (2025-2032)
12.1.2 Global Molecular Targeted Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Molecular Targeted Therapy by Type (2025-2032)
12.2 Global Molecular Targeted Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Molecular Targeted Therapy Sales (K Units) Forecast by Application
12.2.2 Global Molecular Targeted Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Molecular Targeted Therapy Market Size Comparison by Region (M USD)
Table 5. Global Molecular Targeted Therapy Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Molecular Targeted Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Molecular Targeted Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Molecular Targeted Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Targeted Therapy as of 2022)
Table 10. Global Market Molecular Targeted Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Molecular Targeted Therapy Sales Sites and Area Served
Table 12. Manufacturers Molecular Targeted Therapy Product Type
Table 13. Global Molecular Targeted Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Molecular Targeted Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Targeted Therapy Market Challenges
Table 22. Global Molecular Targeted Therapy Sales by Type (K Units)
Table 23. Global Molecular Targeted Therapy Market Size by Type (M USD)
Table 24. Global Molecular Targeted Therapy Sales (K Units) by Type (2019-2025)
Table 25. Global Molecular Targeted Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Molecular Targeted Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Molecular Targeted Therapy Market Size Share by Type (2019-2025)
Table 28. Global Molecular Targeted Therapy Price (USD/Unit) by Type (2019-2025)
Table 29. Global Molecular Targeted Therapy Sales (K Units) by Application
Table 30. Global Molecular Targeted Therapy Market Size by Application
Table 31. Global Molecular Targeted Therapy Sales by Application (2019-2025) & (K Units)
Table 32. Global Molecular Targeted Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Molecular Targeted Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Molecular Targeted Therapy Market Share by Application (2019-2025)
Table 35. Global Molecular Targeted Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Molecular Targeted Therapy Sales by Region (2019-2025) & (K Units)
Table 37. Global Molecular Targeted Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Molecular Targeted Therapy Sales by Country (2019-2025) & (K Units)
Table 39. Europe Molecular Targeted Therapy Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Molecular Targeted Therapy Sales by Region (2019-2025) & (K Units)
Table 41. South America Molecular Targeted Therapy Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Molecular Targeted Therapy Sales by Region (2019-2025) & (K Units)
Table 43. Global Molecular Targeted Therapy Production (K Units) by Region (2019-2025)
Table 44. Global Molecular Targeted Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Molecular Targeted Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Phoenix Molecular Designs Molecular Targeted Therapy Basic Information
Table 52. Phoenix Molecular Designs Molecular Targeted Therapy Product Overview
Table 53. Phoenix Molecular Designs Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Phoenix Molecular Designs Business Overview
Table 55. Phoenix Molecular Designs Molecular Targeted Therapy SWOT Analysis
Table 56. Phoenix Molecular Designs Recent Developments
Table 57. Prelude Therapeutics Molecular Targeted Therapy Basic Information
Table 58. Prelude Therapeutics Molecular Targeted Therapy Product Overview
Table 59. Prelude Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Prelude Therapeutics Business Overview
Table 61. Prelude Therapeutics Molecular Targeted Therapy SWOT Analysis
Table 62. Prelude Therapeutics Recent Developments
Table 63. Tempus Molecular Targeted Therapy Basic Information
Table 64. Tempus Molecular Targeted Therapy Product Overview
Table 65. Tempus Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Tempus Molecular Targeted Therapy SWOT Analysis
Table 67. Tempus Business Overview
Table 68. Tempus Recent Developments
Table 69. Bracco Molecular Targeted Therapy Basic Information
Table 70. Bracco Molecular Targeted Therapy Product Overview
Table 71. Bracco Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Bracco Business Overview
Table 73. Bracco Recent Developments
Table 74. iOmx Therapeutics Molecular Targeted Therapy Basic Information
Table 75. iOmx Therapeutics Molecular Targeted Therapy Product Overview
Table 76. iOmx Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. iOmx Therapeutics Business Overview
Table 78. iOmx Therapeutics Recent Developments
Table 79. OncoDNA Molecular Targeted Therapy Basic Information
Table 80. OncoDNA Molecular Targeted Therapy Product Overview
Table 81. OncoDNA Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. OncoDNA Business Overview
Table 83. OncoDNA Recent Developments
Table 84. Sapience Therapeutics Molecular Targeted Therapy Basic Information
Table 85. Sapience Therapeutics Molecular Targeted Therapy Product Overview
Table 86. Sapience Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Sapience Therapeutics Business Overview
Table 88. Sapience Therapeutics Recent Developments
Table 89. Caris Life Sciences Molecular Targeted Therapy Basic Information
Table 90. Caris Life Sciences Molecular Targeted Therapy Product Overview
Table 91. Caris Life Sciences Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Caris Life Sciences Business Overview
Table 93. Caris Life Sciences Recent Developments
Table 94. Hera Biolabs Molecular Targeted Therapy Basic Information
Table 95. Hera Biolabs Molecular Targeted Therapy Product Overview
Table 96. Hera Biolabs Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Hera Biolabs Business Overview
Table 98. Hera Biolabs Recent Developments
Table 99. CV6 Therapeutics Molecular Targeted Therapy Basic Information
Table 100. CV6 Therapeutics Molecular Targeted Therapy Product Overview
Table 101. CV6 Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. CV6 Therapeutics Business Overview
Table 103. CV6 Therapeutics Recent Developments
Table 104. Carrick Therapeutics Molecular Targeted Therapy Basic Information
Table 105. Carrick Therapeutics Molecular Targeted Therapy Product Overview
Table 106. Carrick Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Carrick Therapeutics Business Overview
Table 108. Carrick Therapeutics Recent Developments
Table 109. Foundation Medicine Molecular Targeted Therapy Basic Information
Table 110. Foundation Medicine Molecular Targeted Therapy Product Overview
Table 111. Foundation Medicine Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Foundation Medicine Business Overview
Table 113. Foundation Medicine Recent Developments
Table 114. Cybrexa Therapeutics Molecular Targeted Therapy Basic Information
Table 115. Cybrexa Therapeutics Molecular Targeted Therapy Product Overview
Table 116. Cybrexa Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Cybrexa Therapeutics Business Overview
Table 118. Cybrexa Therapeutics Recent Developments
Table 119. Global Molecular Targeted Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 120. Global Molecular Targeted Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Molecular Targeted Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 122. North America Molecular Targeted Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Molecular Targeted Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 124. Europe Molecular Targeted Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Molecular Targeted Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 126. Asia Pacific Molecular Targeted Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Molecular Targeted Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 128. South America Molecular Targeted Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Molecular Targeted Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Molecular Targeted Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Molecular Targeted Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 132. Global Molecular Targeted Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Molecular Targeted Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 134. Global Molecular Targeted Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 135. Global Molecular Targeted Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Molecular Targeted Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Targeted Therapy Market Size (M USD), 2019-2032
Figure 5. Global Molecular Targeted Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Molecular Targeted Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Targeted Therapy Market Size by Country (M USD)
Figure 11. Molecular Targeted Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Molecular Targeted Therapy Revenue Share by Manufacturers in 2023
Figure 13. Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Molecular Targeted Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Molecular Targeted Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Molecular Targeted Therapy Market Share by Type
Figure 18. Sales Market Share of Molecular Targeted Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Molecular Targeted Therapy by Type in 2023
Figure 20. Market Size Share of Molecular Targeted Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Molecular Targeted Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Molecular Targeted Therapy Market Share by Application
Figure 24. Global Molecular Targeted Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Molecular Targeted Therapy Sales Market Share by Application in 2023
Figure 26. Global Molecular Targeted Therapy Market Share by Application (2019-2025)
Figure 27. Global Molecular Targeted Therapy Market Share by Application in 2023
Figure 28. Global Molecular Targeted Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Molecular Targeted Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Molecular Targeted Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Molecular Targeted Therapy Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Molecular Targeted Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Molecular Targeted Therapy Sales Market Share by Country in 2023
Figure 37. Germany Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Molecular Targeted Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Molecular Targeted Therapy Sales Market Share by Region in 2023
Figure 44. China Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Molecular Targeted Therapy Sales and Growth Rate (K Units)
Figure 50. South America Molecular Targeted Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Molecular Targeted Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Molecular Targeted Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Molecular Targeted Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Molecular Targeted Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Molecular Targeted Therapy Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Molecular Targeted Therapy Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Molecular Targeted Therapy Production (K Units) Growth Rate (2019-2025)
Figure 65. China Molecular Targeted Therapy Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Molecular Targeted Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Molecular Targeted Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Molecular Targeted Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Molecular Targeted Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Molecular Targeted Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Molecular Targeted Therapy Market Share Forecast by Application (2025-2032)
